INDIAN generics maker Dr
Reddy’s Laboratories has been
banned from selling a generic
version of Sanofi-Aventis’ Allegra
D24 (fexoenadine/pseudoephedrine
extended release) in the US, after a
New Jersey court granted a
preliminary injunction sought by
Sanofi-Aventis.
Sanofi is alleging that Dr Reddy’s
has infringed patents relating to the
manufacturing process of the drug
- rather than the molecule itself
which had its patent protection
expire in 2001.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jun 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jun 10
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.